218 related articles for article (PubMed ID: 33525641)
1. Congenital Diarrhea and Cholestatic Liver Disease: Phenotypic Spectrum Associated with MYO5B Mutations.
Aldrian D; Vogel GF; Frey TK; Ayyıldız Civan H; Aksu AÜ; Avitzur Y; Ramos Boluda E; Çakır M; Demir AM; Deppisch C; Duba HC; Düker G; Gerner P; Hertecant J; Hornová J; Kathemann S; Koeglmeier J; Koutroumpa A; Lanzersdorfer R; Lev-Tzion R; Lima R; Mansour S; Meissl M; Melek J; Miqdady M; Montoya JH; Posovszky C; Rachman Y; Siahanidou T; Tabbers M; Uhlig HH; Ünal S; Wirth S; Ruemmele FM; Hess MW; Huber LA; Müller T; Sturm E; Janecke AR
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33525641
[TBL] [Abstract][Full Text] [Related]
2. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease.
Szperl AM; Golachowska MR; Bruinenberg M; Prekeris R; Thunnissen AM; Karrenbeld A; Dijkstra G; Hoekstra D; Mercer D; Ksiazyk J; Wijmenga C; Wapenaar MC; Rings EH; van IJzendoorn SC
J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):307-13. PubMed ID: 21206382
[TBL] [Abstract][Full Text] [Related]
4. MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update.
Dhekne HS; Pylypenko O; Overeem AW; Zibouche M; Ferreira RJ; van der Velde KJ; Rings EHHM; Posovszky C; van der Sluijs P; Swertz MA; Houdusse A; van IJzendoorn SCD
Hum Mutat; 2018 Mar; 39(3):333-344. PubMed ID: 29266534
[TBL] [Abstract][Full Text] [Related]
5. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
[TBL] [Abstract][Full Text] [Related]
6. Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B Mutations.
Hess MW; Krainer IM; Filipek PA; Witting B; Gutleben K; Vietor I; Zoller H; Aldrian D; Sturm E; Goldenring JR; Janecke AR; Müller T; Huber LA; Vogel GF
J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33924896
[TBL] [Abstract][Full Text] [Related]
7. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
[TBL] [Abstract][Full Text] [Related]
8. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
[TBL] [Abstract][Full Text] [Related]
9. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
Bowman DM; Kaji I; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026
[TBL] [Abstract][Full Text] [Related]
10. Microvillus Inclusion Disease Caused by
Andreassen BU; Aunsholt L; Østergaard E; Ek J; Maroun LL; Jørgensen MH
JPGN Rep; 2023 May; 4(2):e309. PubMed ID: 37200712
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
[TBL] [Abstract][Full Text] [Related]
12. MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.
Wang L; Qiu YL; Xu HM; Zhu J; Li SJ; OuYang WX; Yang YF; Lu Y; Xie XB; Xing QH; Wang JS
Liver Int; 2022 Feb; 42(2):402-411. PubMed ID: 34811877
[TBL] [Abstract][Full Text] [Related]
13. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
[TBL] [Abstract][Full Text] [Related]
14. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
[TBL] [Abstract][Full Text] [Related]
15. Identification of intestinal ion transport defects in microvillus inclusion disease.
Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121
[TBL] [Abstract][Full Text] [Related]
16. A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.
Overeem AW; Li Q; Qiu YL; Cartón-García F; Leng C; Klappe K; Dronkers J; Hsiao NH; Wang JS; Arango D; van Ijzendoorn SCD
Hepatology; 2020 Jul; 72(1):213-229. PubMed ID: 31750554
[TBL] [Abstract][Full Text] [Related]
17. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
Kaji I; Roland JT; Watanabe M; Engevik AC; Goldstein AE; Hodges CA; Goldenring JR
Gastroenterology; 2020 Oct; 159(4):1390-1405.e20. PubMed ID: 32534933
[TBL] [Abstract][Full Text] [Related]
19. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
[TBL] [Abstract][Full Text] [Related]
20. Risk and Clinical Significance of Idiopathic Preterm Birth in Microvillus Inclusion Disease.
Leng C; Sun Y; van IJzendoorn SCD
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
